Today: 8 June 2026
Browse Category

LSE:GSK.L 28 November 2025 - 2 March 2026

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

GSK shares rose 1.1% to 2,263 pence after the European Commission approved its twice-yearly asthma drug Exdensur and the company launched a new tranche of share buybacks. GSK will repurchase up to £0.45 billion in shares by April 24. The company also reported new real-world data showing its RSV vaccine Arexvy was 75.6% effective against RSV-related hospitalisation in adults over 60.
18 February 2026
··
GSK stock price in focus before London open after China starts Arexvy review

GSK stock price in focus before London open after China starts Arexvy review

China’s Center for Drug Evaluation has accepted GSK’s Arexvy RSV vaccine application for review, with a decision expected in 2027. GSK shares closed Tuesday up 0.42% at 2,168 pence ahead of the London open. JPMorgan raised its target price to £22.50, and the company’s next dividend goes ex-dividend on Feb. 19. Non-executive director Hal Barron sold 67,602 ADSs at $59.17 on Feb. 5.
11 February 2026
·
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares slipped 0.6% to 1,879.5p in London by 10:50 GMT as investors awaited detailed data from its phase III hepatitis B drug trial. Analysts pressed for cure rate and durability figures after GSK withheld specifics. A royalty dispute over cancer drug Jemperli is pending in U.S. court, with a trial set for July 2026. Investors are watching for updates at the Jan. 13 J.P. Morgan conference and Feb. 4 results.
9 January 2026
···
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
9 December 2025
···········
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The FTSE 100 closed near 9,660 on December 8, posting a total return of about 20–23% year-to-date, its best run since 2009. The Bank of England has held rates at 4% since August, with inflation at 3.6%. Markets expect a rate cut to 3.75% at the December 18 meeting. UK mortgage rates have dropped to their lowest since before September 2022.
8 December 2025
·········
GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK shares traded near 12-month highs on November 28, 2025, with London shares at 1,806p, up 0.2%, and New York ADRs at $48.02, just below their yearly peak. MarketBeat issued a fresh “Hold” consensus from seven analysts, with an average 12-month price target of $44.13, under current levels. The stock’s recent gains follow continued share buybacks and a busy drug pipeline.
28 November 2025
··

Stock Market Today

  • Ontario Teachers’ Pension Could Gain $11 Billion From SpaceX IPO
    June 8, 2026, 12:29 PM EDT. The Ontario Teachers' Pension Plan, Canada's largest single-profession pension fund managing $279.4 billion, may see returns nearing $11 billion from its $220 million SpaceX investment made in 2019. SpaceX aims for a $1.75 trillion IPO on Nasdaq, pricing shares at $135 each. The fund's CIO, Gillian Brown, indicated the IPO might not be their exit point, citing potential further growth after SpaceX's xAI acquisition. Despite a 30% venture growth portfolio rise in 2025 boosted by SpaceX, the pension plan has faced setbacks, including a total loss from FTX's 2022 collapse. Analysts like Morningstar caution that SpaceX's valuation could be overestimated. Elon Musk, owning 41% of SpaceX, could become the first trillionaire if the IPO meets expectations.

Latest articles

Boeing Stock Gets New Trigger, Cash Still Main Question

Boeing Stock Gets New Trigger, Cash Still Main Question

8 June 2026
Boeing’s 777X program cleared a major FAA-supervised test phase, spotlighting certification progress as shares edged up 0.3% to $216.01; with a $695 billion backlog and negative $1.5 billion free cash flow last quarter, investors now focus on Boeing’s ability to convert orders into deliveries and cash amid ongoing production and regulatory risks.
Apple Faces Key AI Event, Wall Street Focuses on Siri

Apple Faces Key AI Event, Wall Street Focuses on Siri

8 June 2026
Apple shares jumped 2.2% to $314.17 ahead of its WWDC keynote as investors awaited AI updates, especially to Siri; with the stock up 15% since April and trading at 34 times projected earnings, analysts warn much optimism is already priced in, raising the risk of a pullback if Apple’s AI announcements disappoint.
Oklo Shares Climb After Manufacturing Pact, July Remains in Focus

Oklo Shares Climb After Manufacturing Pact, July Remains in Focus

8 June 2026
Oklo shares jumped 3% to $59.86 after acquiring ARMEC, expanding in-house reactor and fuel-manufacturing capability as investors weigh its $10.2 billion valuation despite zero revenue and a $33.1 million Q1 loss; the deal addresses criticism over lack of operating assets, but Oklo’s path to power sales still depends on regulatory milestones and fuel supply, with key test reactor results expected in July.
TSMC Chip Bottleneck Turns Into Global Concern

TSMC Chip Bottleneck Turns Into Global Concern

8 June 2026
TSMC’s CEO warned shareholders that global chip supply will fall short of AI-driven demand for years, even as the company forecasts over 30% sales growth in 2025; TSMC’s U.S.-listed shares rose 3.8% to $431.12, while Intel surged 12.6% after Google reportedly ordered future AI chips, highlighting rising supply chain risks and market concentration.
Dow Jones gains with chip stocks ahead of inflation data

Dow Jones gains with chip stocks ahead of inflation data

8 June 2026
Chip stocks surged, powering the Nasdaq up 1.72% and the S&P 500 1.09% higher, while the Dow rose 0.48% to 51,110 as investors bought back Friday’s losses after a strong jobs report fueled Fed-rate worries; May CPI inflation data Wednesday and oil prices remain key risks for market direction.
Go toTop